Abstract: Systems and techniques are described for depth sensing. For example, a method can include obtaining a first depth image of a scene. The first depth image of the scene is associated with a first illumination configuration including illuminating the scene with a first type of illumination. The method can include obtaining a second depth image of the scene, wherein the second depth image is associated with a second illumination configuration, different from the first illumination configuration. The second illumination configuration includes illuminating the scene with a second type of illumination. The method can include determining, based on the second depth image, multipath interference (MPI) associated with the first depth image. The method can further include generating based on determining the MPI associated with the first depth image an adjusted depth image including one or more pixels from the first depth image and one or more adjusted pixels.

Abstract: The disclosure relates to KRASG12D inhibitor compounds having the structure of Formula (A) or Formula (B), pharmaceutical compositions thereof, and methods of use thereof for inhibiting, treating, and/or preventing KRASG12D mutation-associated diseases, disorders and conditions.

Abstract: A writing panel includes an array substrate, a flexible substrate disposed opposite to the array substrate, a liquid crystal layer disposed between the array substrate and the flexible substrate, and a plurality of spacers each in a shape of a column disposed on a surface of the array substrate proximate to the liquid crystal layer. The array substrate includes a base and a pixel driving circuit layer disposed on the base, and the pixel driving circuit layer includes a plurality of thin film transistors and a plurality of signal lines. An orthographic projection of each spacer on the base is non-overlapping with orthographic projections of the plurality of thin film transistors and the plurality of signal lines on the base.

Abstract: An image compression sampling method and assembly are provided. The method includes: performing sparse representation on a target image by using an initial sparse matrix, quantifying an initial sparse representation result to obtain an optimized sparse representation result, and obtaining an optimized sparse matrix; constructing a product matrix by using the optimized sparse matrix and an initial measurement matrix, and adjusting absolute values of off-diagonal elements in the product matrix to be less than a correlation threshold; performing singular value decomposition on the product matrix to obtain a diagonal matrix and a left singular matrix, and updating the diagonal matrix according to a quantity of samplings of the initial measurement matrix; and optimizing the initial measurement matrix by using the left singular matrix and the updated diagonal matrix to obtain an optimized measurement matrix, and collecting image data by using the optimized sparse matrix and the optimized measurement matrix.

Abstract: The present disclosure relates to a system and a method for image reconstruction. The method may include obtaining a projection image of a subject acquired by an imaging device, the projection image including a first region with a normal exposure corresponding to a first portion of the subject and a second region with an overexposure corresponding to a second portion of the subject; using first pixel values of first pixels in the first region to correct second pixel values of second pixels in the second region; and reconstructing, based on the first pixel values of the first pixels in the first region and the corrected second pixel values of the second pixels in the second region, a target image of the subject.

Abstract: A method for controlling lane changing of a vehicle, including: receiving a lane changing instruction (step 101); acquiring a speed parameter of the vehicle (step 102); according to the speed parameter, determining a controlling coefficient of a predetermined controller (step 103); acquiring a position-deviation parameter and a heading-angle parameter of the vehicle; if the position-deviation parameter is greater than or equal to a first threshold, or, if the heading-angle parameter is greater than or equal to a second threshold, according to the controlling coefficient, the position-deviation parameter and the heading-angle parameter, determining a target steering-wheel steering angle of the vehicle; and according to the target steering-wheel steering angle, controlling the vehicle to perform a lane changing operation, till the position-deviation parameter is less than the first threshold, and the heading-angle parameter is less than the second threshold (step 105).

Abstract: The disclosure relates to bifunctional KRAS-G12D-modulating compounds having the structure W-L-T, where W is a targeting group that binds specifically to KRAS-G12D protein, T is an E3-ligase binding group, and L is absent or is a bivalent linking group that connects W and T together via a covalent linkage. Compounds and pharmaceutical compositions thereof can promote degradation of the KRAS-G12D protein in a cell and are thus useful for treating, inhibiting, and preventing KRAS-G12D-associated diseases, disorders and conditions, including cancers.

Abstract: The disclosure relates to bifunctional CDK-modulating compounds having the structure W-L-T, where W is a targeting group that binds specifically to a CDK protein, T is an E3-ligase binding group, and L is absent or is a bivalent linking group that connects W and T together via a covalent linkage. Compounds and pharmaceutical compositions thereof can promote degradation of one or more CDK protein in a cell and are thus useful for treating, inhibiting, and preventing CDK-associated diseases, disorders and conditions, including cancers.

Abstract: A powder injection of a donepezil semi palmoxiric acid salt, a composition containing the same and a preparation method therefor. The powder injection contains donepezil semi palmoxiric acid salt crystals having an average particle size of 2-52 ?m.

Abstract: Disclosed is a salt form of an isoquinolinone type compound as a ROCK protein kinase inhibitor and a preparation method therefor, and use of the salt form in the preparation of a medicament for treating glaucoma or ocular hypertension is further included.

Abstract: The disclosure relates to bifunctional KRAS-G12D-modulating compounds having the structure W-L-T, where W is a targeting group that binds specifically to KRAS-G12D protein, T is an E3-ligase binding group, and L is absent or is a bivalent linking group that connects W and T together via a covalent linkage. Compounds and pharmaceutical compositions thereof can promote degradation of the KRAS-G12D protein in a cell and are thus useful for treating, inhibiting, and preventing KRAS-G12D-associated diseases, disorders and conditions, including cancers.

Abstract: The disclosure uses the Carter's coefficient to correct the equivalent electromagnetic air gap length. And the specific permeance on both sides of the primary core is obtained. Then, the permeance on both sides based on the structure of the primary core is calculated. An equation is established by using the continuity principle of flux, thereby obtaining the air gap magnetomotive force model of current-carrying conductor. The slot vector diagram of magnetomotive force in short primary linear machine is illustrated according to that in the rotating machine. Then, based on the winding arrangement and vector combination, the amplitude and phase of various spatial harmonic wave of the three-phase winding are obtained. Finally, the characteristics of average component distribution of the current-carrying conductor are adopted to obtain the pulsating magnetomotive force generated by the three-phase winding of the linear machine.

Abstract: Related are a JAK kinase inhibitor, a preparation method for same, and applications thereof in the field of medicine, related to the field of medicinal chemistry. Provided is a novel small molecule JAK inhibitor, which has the structure as represented by formula (II). The compound provides improved efficacy and safeness in preventing or treating a JAK-related indication.

Abstract: The disclosure uses the Carter's coefficient to correct the equivalent electromagnetic air gap length. And the specific permeance on both sides of the primary core is obtained. Then, the permeance on both sides based on the structure of the primary core is calculated. An equation is established by using the continuity principle of flux, thereby obtaining the air gap magnetomotive force model of current-carrying conductor. The slot vector diagram of magnetomotive force in short primary linear machine is illustrated according to that in the rotating machine. Then, based on the winding arrangement and vector combination, the amplitude and phase of various spatial harmonic wave of the three-phase winding are obtained. Finally, the characteristics of average component distribution of the current-carrying conductor are adopted to obtain the pulsating magnetomotive force generated by the three-phase winding of the linear machine.

Abstract: The present invention relates to a preparation method for an amide compound and an application thereof in the field of medicine. Specifically, provided by the present invention is an amide small molecule compound which is an inhibitor of Zeste gene enhancer homolog 2 (EZH2) and which may be used to prevent and/or treat EZH2-mediated related diseases, comprising tumors, myeloproliferative diseases or autoimmune diseases.

Abstract: A powder injection of a donepezil semi palmoxiric acid salt, a composition containing the same and a preparation method therefor. The powder injection contains donepezil semi palmoxiric acid salt crystals having an average particle size of 2-52 ?m.

Abstract: Provided are a preparation method for amide compounds and use thereof in medical field. Specifically, provided are small molecule amide compounds. Such compounds are inhibitors of enhancer homolog 2 (EZH2) of Zeste gene, and can be used for preventing and/or treating related diseases mediated by EZH2, including tumors, myeloproliferative diseases or autoimmune diseases.

Abstract: A bipolar bidirectional DC converter comprises at least two valve group series (101, 102) and at least six magnetic elements (103), and said valve group series are divided into a Type-I valve group series (102) and a Type-II valve group series (101) each valve group series (101, 102) comprises a high-voltage DC port, a low-voltage DC port and at least three AC ports, and each AC port is connected to a magnetic element (103); and the other ends of the magnetic elements (103), which are connected to all the AC ports in the same valve group series (101, 102), are connected.

Abstract: A powder injection of a donepezil semi palmoxiric acid salt, a composition containing the same and a preparation method therefor. The powder injection contains donepezil semi palmoxiric acid salt crystals, and the average grain size of the crystals ranges from 0.5 ?m to 100 ?m.

Abstract: A molecular marker for the selection and breeding of fine-wool sheep is disclosed. The marker is an STR marker comprising a (CA)n repeat core sequence, with n between 5 and 24 that can be obtained by PCR amplification of genomic DNA of sheep using the primers shown in SEQ ID NO: 1 and SEQ ID NO: 2 and sequencing the PCR product. When n is 17 or 18, a sheep is a fine-wool breed, and when n is 23 or 24, a sheep is a non-fine-wool breed. When the CA repeat is discontinuous, i.e., divided into two segments (e.g., 12+11 or 13+11) separated by two bases TA or GA, a sheep is a hybrid breed of fine-wool sheep and non-fine-wool sheep. Use of the marker provides methods of identifying of fine-wool sheep breeds, and efficient and accurate selection of fine-wool sheep or the hybrid offspring of fine-wool sheep for breeding.